UPCC 29421: Administration of HIV-specific T cells to HIV+ Patients Receiving High Dose Chemotherapy Followed by Autologous Stem Cell Rescue -Auto-RESIST
Enrolling By Invitation
99 years and younger
All
Phase
N/A
1 Location
Brief description of study
Were doing this study to see if a type of cells called HST-NEETs can help the body fight HIV. HST-NEETs are cells made from immune cells that have been treated and grown in a lab. This is a phase 2 study.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Medical Research
-
Age: - 99 Years
-
Gender: All
TBD
Updated on
01 Aug 2024.
Study ID: 849746
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu
For cancer trials contact EmergingMed: 1-855-216-0098 or PennCancerTrials@emergingmend.com
